PPG
57
-3
SBUX
37
-2
DHR
32
-6
URBN
48
-6
CAT
59
-2
CNP
54
10
V
64
-2
IPG
34
-9
MMM
35
-5
RL
69
-4
IRM
41
3
O
17
-13
AMT
37
3
MDLZ
32
-4
AIV
64
4
CVS
41
-4
CI
45
-3
MCO
71
-7
NAVI
52
-2
COST
57
-6
PPG
57
-3
SBUX
37
-2
DHR
32
-6
URBN
48
-6
CAT
59
-2
CNP
54
10
V
64
-2
IPG
34
-9
MMM
35
-5
RL
69
-4
IRM
41
3
O
17
-13
AMT
37
3
MDLZ
32
-4
AIV
64
4
CVS
41
-4
CI
45
-3
MCO
71
-7
NAVI
52
-2
COST
57
-6
Financhill
Back

ADC Therapeutics SA 10K Form

Sell
27

ADCT
ADC Therapeutics SA

Last Price:
2.39
Seasonality Move:
199.95%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ADCT News And Ratings

See the #1 stock for the next 7 days that we like better than ADCT

ADCT Financial Statistics

Sales & Book Value

Annual Sales: $69.56M
Cash Flow: $-25.26M
Price / Cash Flow: 0
Annual Sales: $-1.78
Price / Book: 0

Profitability

EPS (TTM): -2.40000
Net Income (TTM): $-212.15M
Gross Margin: $67.03M
Return on Equity: 0%
Return on Assets: -57.32%

ADC Therapeutics SA Earnings Forecast

Key ADC Therapeutics SA Financial Ratios

  • The Gross Profit Margin over the past 5 years for ADCT is 96.36%.
  • The Selling, General & Administrative Expenses for ADCT have been equal to 152.23% of Gross Profit Margin.
  • The Research & Development expenses have been 182.76% of Revenue.
  • The Interest Expense is -19.30% of Operating Income.
  • The Net Earning history of ADCT is -345.11% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

ADC Therapeutics SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Health Care
Current Symbol: ADCT
CUSIP: H0036K
Website: adctherapeutics.com

Debt

Debt-to-Equity Ratio: -0.66
Current Ratio: 4.92
Quick Ratio: 4.41

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ADCT Technical Analysis vs Fundamental Analysis

Sell
27
ADC Therapeutics SA (ADCT) is a Sell

Is ADC Therapeutics SA a Buy or a Sell?